NeuroMetrix, Inc. (NASDAQ: NURO) Shares Surge on FDA Clearance: U.S. Daily Market Movers

Published:

Small
cap stocks making big moves on Tuesday, July 8, 2014 (as of 4 pm EST)

NeuroMetrix, Inc. (NASDAQ: NURO)
shares powered 24% higher to $2.34 on volume of more than 7.6 million shares
Tuesday after the health-care company announced that its wearable technology
for treatment of chronic pain received 510(k) clearance from the U.S. Food and
Drug Administration (FDA) for over-the-counter use.

As well,
shares of Actions Semiconductor Co.,
Ltd.
(NASDAQ:
ACTS
) slid 13% to $2.08 as the Chinese fabless semiconductor company said
it is lowering its revenue guidance for Q2 of 2014 to approximately $12 million
from its previous forecast of $15 million to $17 million, due primarily to soft
overall demand from whitebox tablet manufacturers.

TherapeuticsMD (NASDAQ: TXMD)
stock, meanwhile, popped 33% to $5.47 after FBR
Capital initiated coverage on the pharmaceutical company with an
“outperform” rating and a $34 price target. TherapeuticsMD is
developing a treatment for post-menopausal vasomotor symptoms, such as hot
flashes.

Finally,
BioAmber (NYSE: BIOA)
shares climbed 17% to $12 after the industrial biotechnology company reported
that it has signed a 210,000 ton per year take-or-pay contract for bio-based
succinic acid with Vinmar International, as part of a 15-year master off-take
agreement. 

Related articles

Recent articles